Interferon beta and long-term disability in multiple sclerosis

JAMA Neurology

Volumn 70, Issue 5, 2013, Pages 651-652

  Shirani, Afsaneh ^a   Zhao, Yinshan ^b   Karim, Mohammad Ehsanul ^b   Evans, Charity ^a   Kingwell, Elaine ^a   Van Der Kop, Mia L ^a   Oger, Joel ^a   Gustafson, Paul ^b   Petkau, John ^b   Tremlett, Helen ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON;

AGE; COHORT ANALYSIS; DISABILITY; DISEASE DURATION; EXPANDED DISABILITY STATUS SCALE; HUMAN; MULTIPLE SCLEROSIS; NOTE; PREDICTION; PRIORITY JOURNAL; RELAPSE; SHORT COURSE THERAPY; TREATMENT OUTCOME;

EID: 84877726848     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2013.2197     Document Type: Note

References (19)

1. Greenberg BM, Balcer L, Calabresi PA, et al. Interferon beta use and disability prevention in relapsing-remitting multiple sclerosis. JAMA Neurol. 2013;70(2):248-251.
2. Shirani A, Zhao Y, Karim ME, et al. Association between use of interferon beta and progression of disability in patients with relapsing-remitting multiple sclerosis. JAMA. 2012;308(3):247-256.
3. Jacobs LD, Cookfair DL, Rudick RA, et al The Multiple Sclerosis Collaborative Research Group (MSCRG). Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. Ann Neurol. 1996;39(3):285-294. (Pubitemid 26100751)
4. Hartung HP, Flachenecker P, Weilbach FX, Rieckmann P. PRISMS Study: interferon-beta 1a (Rebif) in relapsing multiple sclerosis [in German]. Nervenarzt. 1999;70(2):182-185. (Pubitemid 29152337)
5. Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. N Engl J Med. 2000;343(20):1430-1438.
6. Scalfari A, Neuhaus A, Degenhardt A, et al. The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability. Brain. 2010;133(Pt 7):1914-1929.
7. Ebers GC, Traboulsee A, Li D, et al; Investigators of the 16-year Long-Term Follow-Up Study. Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial. J Neurol Neurosurg Psychiatry. 2010;81(8):907-912.
8. Tremlett H, YousefiM, Devonshire V, Rieckmann P, Zhao Y; UBC Neurologists. Impact of multiple sclerosis relapses on progression diminishes with time. Neurology. 2009;73(20):1616-1623.
9. Trojano M, Pellegrini F, Fuiani A, et al. New natural history of interferon-beta-treated relapsing multiple sclerosis. Ann Neurol. 2007;61(4):300-306. (Pubitemid 46676729)
10. Renoux C, Suissa S. Immortal time bias in the study of effectiveness of interferon-beta in multiple sclerosis. Ann Neurol. 2008;64(1):109-110, author reply 110.
11. Koch M, Mostert J, De Keyser J, Tremlett H, FilippiniG. Interferon-beta treatment and the natural history of relapsing-remitting multiple sclerosis. Ann Neurol. 2008;63(1):125-126, author reply 126-127.
12. Robins JM, Hernán MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology. 2000;11(5):550-560. (Pubitemid 30660034)
13. Goodin DS, Reder AT, Cutter G. Treatment with interferon beta for multiple sclerosis. JAMA. 2012;308(16):1627-1628, author reply 1627-1628.
14. Confavreux C, Vukusic S. Age at disability milestones in multiple sclerosis. Brain. 2006;129(pt 3):595-605. (Pubitemid 43278222)
15. Tremlett H, Paty D, Devonshire V. Disability progression in multiple sclerosis is slower than previously reported. Neurology. 2006;66(2):172-177. (Pubitemid 43970148)
16. Tremlett H, Zhao Y, Rieckmann P, Hutchinson M. New perspectives in the natural history of multiple sclerosis. Neurology. 2010;74(24):2004-2015.
17. Rice GP, Incorvaia B, Munari L, et al. Interferon in relapsing-remitting multiple sclerosis. Cochrane Database Syst Rev. 2001;(4):CD002002.
18. Filippini G, Munari L, Incorvaia B, et al. Interferons in relapsing remitting multiple sclerosis: a systematic review. Lancet. 2003;361(9357):545- 552. (Pubitemid 36207471)
19. La Mantia L, Vacchi L, Di Pietrantonj C, et al. Interferon beta for secondary progressive multiple sclerosis. Cochrane Database Syst Rev. 2012;1:CD005181.